Long-term safety profile of ixekizumab in patients with moderate-to-severe plaque psoriasis: an integrated analysis from 11 clinical trials

doi:10.1111/jdv.15242

Long-term safety profile of ixekizumab in patients with moderate-to-severe plaque psoriasis: an integrated analysis from 11 clinical trials

科研成果: 期刊稿件 › 文章 › 同行评审

源语言	英语
页（从-至）	333-339
页数	7
期刊	Journal of the European Academy of Dermatology and Venereology
卷	33
期	2
DOI	https://doi.org/10.1111/jdv.15242
出版状态	已出版 - 2月 2019
已对外发布	是

!!!ASJC Scopus Subject Areas

皮肤医学
传染病学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1111/jdv.15242

其它文件与链接

引用此

@article{bafe8788724e41ecb51487902bd94abb,

title = "Long-term safety profile of ixekizumab in patients with moderate-to-severe plaque psoriasis: an integrated analysis from 11 clinical trials",

note = "Publisher Copyright: {\textcopyright} 2018 European Academy of Dermatology and Venereology",

year = "2019",

month = feb,

doi = "10.1111/jdv.15242",

language = "English",

volume = "33",

pages = "333--339",

journal = "Journal of the European Academy of Dermatology and Venereology",

issn = "0926-9959",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Long-term safety profile of ixekizumab in patients with moderate-to-severe plaque psoriasis

T2 - an integrated analysis from 11 clinical trials

PY - 2019/2

Y1 - 2019/2

UR - http://www.scopus.com/inward/record.url?scp=85057044459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057044459&partnerID=8YFLogxK

U2 - 10.1111/jdv.15242

DO - 10.1111/jdv.15242

M3 - Article

C2 - 30198588

AN - SCOPUS:85057044459

SN - 0926-9959

VL - 33

SP - 333

EP - 339

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

IS - 2

ER -

Long-term safety profile of ixekizumab in patients with moderate-to-severe plaque psoriasis: an integrated analysis from 11 clinical trials

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此